(Q44172555)
Statements
1 reference
Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus (English)
1 reference
Katsunori Ikewaki
1 reference
Keiko Mochizuki
1 reference
Masafumi Iwasaki
1 reference
Ryoichi Nishide
1 reference
Seibu Mochizuki
1 reference
Norio Tada
1 reference
1 October 2002
1 reference
1 reference
51
1 reference
10
1 reference
1348-1354
1 reference
Identifiers
1 reference
1 reference